MediMedia Managed Markets
Managed Care magazine
P&T Community, The Online Resource for P&T Decision Makers
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager

Statement of Purpose
Guidelines for Authors
Editorial Board

Recent Issues

December 2002


Pharmaceutical-Approval Update

Pharmaceutical-Approval Update

Dr. Goldenberg discusses new drugs that have been approved for the treatment of hepatic disease, hypertension, and type 2 diabetes.
Marvin M. Goldenberg, PhD

A Survey of Investigational Drug Services at Academic Health Centers

The authors review the status of resources and requirements at 85 academic health centers in the U.S.
Alan H. Mutnick, PharmD, John A. Armitstead, MS, Thomas W. Cooley, BS, Kenneth Rockwell, Jr., PharmD, MS, and Karl A. Matuszewski, MS, PharmD



Beyond Buy-in

Editor-in-Chief David Nash examines Robert Kegan’s take on why people find it difficult to change.
David B. Nash, MD, MBA

Medication Errors

Optimizing the Use of Computer System Clinical Alerts

Drug-related adverse events can be reduced when computerized pharmacy system alerts are fine-tuned on a regular basis.
Matthew Grissinger

Drug News

New Drugs/Drug News

The latest information about approvals, indication changes, industry updates, and news from the FDA.

Prescription Washington

Bush Administration Attempts to Speed Up Availability of Generic Drugs

Mr. Barlas addresses the government’s interest in accelerating the availability of generic drugs.
Stephen Barlas

Drug Forecast

Olmesartan Medoxomil for Hypertension: A Clinical Review

The authors review a new agent, olmesartan medoxomil, for the treatment of hypertension.
Daryl Norwood, PharmD, Evans Branch III, PharmD, Bridget Smith, MD, and Marlon Honeywell, PharmD